Research Studies

Browse Studies

exPDite-2

Conditions:
PD

Criteria

Ages
45-75
Cognition
No
Dyskinesias
any
Fluctuations
Yes
Tremor
any
Gait
any
DBS
No
Hallucinations
No

About this study

This study will test a new investigational cellular therapy product called Bemdaneprocel (stem cell derived neuronal cells) for people with Parkinson’s Disease who have 2.5 hours or more of daily OFF time. Patients are randomized to either stem cell therapy or placebo. The goal is to improve long-term PD management by improving their ability to move, slowing the disease's progress, and enhancing their quality of life. It also seeks to do this with fewer side effects than current treatments.

Sustain our mission to enhance lives and outcomes through research

As we work to improve patient quality of life — for their entire lifespan — we seek partners to catapult our progress. With your philanthropic investment, we can expand the breadth and depth of our efforts in three critical areas: research, clinical care and education and training.

Support Us